NovaBridge Biosciences

NBPSEC EDGAR
Form 4, Insider transaction

Sean Wuxiong Cao, Chief Bus. Development Officer

Share transactions

M Option exercise
2 parts, 339,372 shares in total
DateTransactionSecuritySharesPriceAmount
September 3, 2026
M Option exercise
Common stock+235,136No costNo cost
September 3, 2026
M Option exercise
Common stock+104,236No costNo cost
Shares held directly after the transactions: 374,445.
Codes A, F and M are not open-market trades.

Official document

NovaBridge Biosciences, Form 4SEC EDGAR file no. 0002109966-26-000006
View document